Rod Raynovich Blog | Asco Rally Fizzles: The Nascent Rally In Biotech Stocks Fades | Talkmarkets
CEO of Raygent Associates
Contributor's Links: Raygent

Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a ... more

Asco Rally Fizzles: The Nascent Rally In Biotech Stocks Fades

Date: Saturday, May 18, 2019 10:59 PM EDT

ASCO Rally Fizzles Two Weeks ahead of May 31-June 4 Meeting: XBI down 0.9% to $83.

NASDAQ Fades down 0.9%.

RISK still OFF.

Here is a brief snapshot of trading today 30 min before close. Without a NASDAQ rally it is unlikely to have biotech’s moving up.

  • Gene Therapy Stocks:red screen except BOLD, MGTX and SRPT.
  • Mid Caps: Mixed but RED with following stocks up:AGIO NKTR SGEN XNCR
  • Large Caps:Flattish with GILD and RHHBY up.IBB down 0.6% to $103.85.
Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.


Leave a comment to automatically be entered into our contest to win a free Echo Show.